Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Senia Maria Rosaria Trabucco"'
Autor:
Gerardo Cazzato, Carmelo Lupo, Nadia Casatta, Flavia Riefoli, Andrea Marzullo, Anna Colagrande, Eliano Cascardi, Senia Maria Rosaria Trabucco, Giuseppe Ingravallo, Biagio Moretti, Eugenio Maiorano, Vito Pesce, Leonardo Resta
Publikováno v:
Diagnostics, Vol 12, Iss 11, p 2616 (2022)
Angiomatoid fibrous histiocytoma (AFH) is a rare neoplasm described for the first time by Enzinger in 1979, and classified by World Health Organization 2020 as intermediate malignant potential neoplasm. It mostly occurs in the subcutis and is charact
Externí odkaz:
https://doaj.org/article/9619f2176c2b42e8908cd11896a91ef7
Autor:
Senia Maria Rosaria Trabucco, Debora Brascia, Gerardo Cazzato, Giulia De Iaco, Anna Colagrande, Francesca Signore, Giuseppe Ingravallo, Leonardo Resta, Giuseppe Marulli
Publikováno v:
Medicina, Vol 57, Iss 6, p 524 (2021)
Pulmonary sclerosing pneumocytoma is a rare benign pulmonary tumor of primitive epithelial origin. Because of the unspecific radiological features mimicking malignancies and its histological heterogeneity, the differential diagnosis with adenocarcino
Externí odkaz:
https://doaj.org/article/5bed7f73291544cfa2003077c2f73d2e
Autor:
Pierluigi Carratù, Silvano Dragonieri, Maria Cristina Nocerino, Senia Maria Rosaria Trabucco, Donato Lacedonia, Giuseppe Parisi, Onofrio Resta
Publikováno v:
Canadian Respiratory Journal, Vol 12, Iss 8, Pp 437-439 (2005)
A 29 year-old-man with Crohn's disease, who developed diffuse pulmonary infiltrates and hypoxemia two months following oral administration of mesalazine, was examined. Clinical findings and computed tomography were suggestive of, and lung histology w
Externí odkaz:
https://doaj.org/article/898f4434fe53414a9cf4c167eb08cda4
Autor:
Donato Lacedonia, Onofrio Resta, Maria Cristina Nocerino, Senia Maria Rosaria Trabucco, Giuseppe Parisi, Silvano Dragonieri, Pierluigi Carratù
Publikováno v:
Canadian Respiratory Journal, Vol 12, Iss 8, Pp 437-439 (2005)
A 29 year-old-man with Crohn's disease, who developed diffuse pulmonary infiltrates and hypoxemia two months following oral administration of mesalazine, was examined. Clinical findings and computed tomography were suggestive of, and lung histology w